Effect of prolonged gonadotropin releasing hormone (GnRH) agonist before IVF versus placebo on CYP19 A1 gene expression in granulosa cells in infertile women with endometriosis

The paper examined whether a prolonged course of a GnRH agonist before IVF, compared with placebo, altered CYP19A1 gene expression in granulosa cells from infertile women with endometriosis. Granulosa cells were obtained in the IVF context, and CYP19A1 expression was assessed as the primary molecular outcome to evaluate ovarian steroidogenic pathway effects. The key finding reported was the comparative change in CYP19A1 gene expression between the GnRH agonist and placebo groups. As a conference submission, it is presented with limited methodological and outcome detail in the provided text, which constrains interpretation of the full effect size and statistical context. This paper is centrally about endometriosis — it specifically studies how GnRH agonist pretreatment before IVF influences CYP19A1 expression in granulosa cells from women with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works